福瑞医科(300049)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300049 福瑞医科

已收盘 08-13 15:00:00

{"stockData":{"symbol":"300049","market":"SZ","secType":"STK","nameCN":"福瑞医科","latestPrice":46.38,"timestamp":1786604598000,"preClose":44.52,"halted":0,"volume":14333955,"delay":0,"changeRate":0.0418,"floatShares":234000000,"shares":264000000,"eps":0.5957,"marketStatus":"已收盘","change":1.86,"latestTime":"08-13 15:00:00","open":44.29,"high":47.85,"low":43.84,"amount":663000000,"amplitude":0.0901,"askPrice":46.38,"askSize":24,"bidPrice":46.37,"bidSize":71,"shortable":0,"etf":0,"ttmEps":0.5957,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786671000000},"marketStatusCode":5,"adr":0,"adjPreClose":44.52,"symbolType":"stock","openAndCloseTimeList":[[1786584600000,1786591800000],[1786597200000,1786604400000]],"highLimit":48.97,"lowLimit":40.07,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":263991100,"isCdr":false,"pbRate":5.93,"roa":"--","peRate":77.857982,"roe":"1.6%","epsLYR":0.58,"committee":0.535897,"marketValue":12244000000,"turnoverRate":0.0614,"status":0,"floatMarketCap":10834000000},"requestUrl":"/m/hq/s/300049","defaultTab":"news","newsList":[{"id":"2658968584","title":"【机构调研记录】嘉实基金调研福瑞医科","url":"https://stock-news.laohu8.com/highlight/detail?id=2658968584","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658968584?lang=zh_cn&edition=full","pubTime":"2026-08-11 08:15","pubTimestamp":1786407305,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月10日披露的机构调研信息，嘉实基金近期对1家上市公司进行了调研，相关名单如下：1）福瑞医科 调研纪要：公司正探索集团化、批量式投放模式，以降低投放及运营成本。Echosens与药企合作涵盖新药研发筛查及上市后学术推广，提升MSH认知度。公司计划与基层医疗机构合作，推动肝脏代谢疾病筛查与管理。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100006090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0096","BK0251","BK0114","BK0028","300049","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658968513","title":"【机构调研记录】华夏基金调研百奥泰、福瑞医科","url":"https://stock-news.laohu8.com/highlight/detail?id=2658968513","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658968513?lang=zh_cn&edition=full","pubTime":"2026-08-11 08:14","pubTimestamp":1786407299,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月10日披露的机构调研信息，华夏基金近期对2家上市公司进行了调研，相关名单如下：1）百奥泰 调研纪要：公司已有6款上市药品，其中4款已在欧美获批，预计到2027年下半年共四款产品在欧美上市。2）福瑞医科 调研纪要：公司正探索集团化、批量式投放模式，以降低投放及运营成本。公司计划与基层医疗机构合作，推动肝脏代谢疾病筛查与管理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100006085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0113","300049","BK0028","688177","BK0146","BK0239","BK0251","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658958722","title":"股市必读：福瑞医科（300049）8月10日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2658958722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658958722?lang=zh_cn&edition=full","pubTime":"2026-08-11 00:59","pubTimestamp":1786381150,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘，福瑞医科报收于42.47元，下跌5.2%，换手率5.41%，成交量12.63万手，成交额5.46亿元。当日关注点交易信息汇总：8月10日主力资金净流出1117.41万元，游资资金净流入3310.99万元。公司已于2025年12月、2026年1月分别召开董事会及股东会，审议发行H股股票及在香港联合交易所有限公司上市等议案；目前尚未向港交所正式递表。公司第二季度设备投放量及业绩表现请关注8月25日披露的半年度报告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100001036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0114","300049","BK0251","BK0146","BK0096","BK0113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658932227","title":"福瑞医科：有知名机构盘京投资参与的多家机构于8月7日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2658932227","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658932227?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:31","pubTimestamp":1786372286,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月10日福瑞医科发布公告称国寿养老、中信建投、盘京投资、建信基金、嘉实基金、华夏基金、工银瑞信、庄贤投资于2026年8月7日调研我司。Echosens新任首席执行官 Romain于 2026年 5月 1日正式上任。目前，公司尚未向港交所正式递表。Theraclion已向美国 FD提交上市许可申请。目前，Theraclion业务已覆盖全球 15个以上国家。答：请投资人关注公司于 8月 25日披露的半年度报告。该股最近90天内共有2家机构给出评级，买入评级2家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000034401.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0146","BK0096","BK0114","BK0028","BK0251","300049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658981300","title":"8月10日福瑞医科跌5.20%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658981300","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658981300?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:48","pubTimestamp":1786351726,"startTime":"0","endTime":"0","summary":"证券之星消息，8月10日福瑞医科跌5.20%，收盘报42.47元，换手率5.41%，成交量12.63万手，成交额5.46亿元。重仓福瑞医科的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000021007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0251","BK0114","BK0146","300049","BK0113","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653336748","title":"7月23日福瑞医科涨9.95%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653336748","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653336748?lang=zh_cn&edition=full","pubTime":"2026-07-23 16:53","pubTimestamp":1784796809,"startTime":"0","endTime":"0","summary":"证券之星消息，7月23日福瑞医科涨9.95%，收盘报45.85元，换手率7.22%，成交量16.86万手，成交额7.8亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为4.23亿元，最新净值0.966，较上一交易日下跌0.45%，近一年下跌13.88%。长城消费增值混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300033446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0251","300049","BK0113","BK0028","BK0114","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653774278","title":"福瑞医科：公司已完成2025年度权益分派工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2653774278","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653774278?lang=zh_cn&edition=full","pubTime":"2026-07-21 17:18","pubTimestamp":1784625496,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞医科(300049)07月21日在投资者关系平台上答复投资者关心的问题。投资者提问：注意到公司五月十三日股东大会通过了分红决议，但是一个半月过去了，公司并未安排分红，公司是不是忘了？超过两个月不执行可能会对公司再融资有影响福瑞医科回复：尊敬的投资人您好！公司已完成2025年度权益分派工作，详情请参考公司于2026年6月26日披露的《2025 年年度权益分派实施公告》。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100031863.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300049","BK0146","BK0028","BK0096","BK0113","BK0114","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653327857","title":"福瑞医科：截止7月10日，公司的股东人数为24490户","url":"https://stock-news.laohu8.com/highlight/detail?id=2653327857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653327857?lang=zh_cn&edition=full","pubTime":"2026-07-21 17:03","pubTimestamp":1784624632,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞医科(300049)07月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司截至7月7日的股东人数是多少？福瑞医科回复：尊敬的投资人您好！根据相关规定，中国证券登记结算有限责任公司深圳分公司每月会向公司提供截至上月最后一个交易日、本月10日和本月20日（该日若为非交易日的，应为该日前一个交易日）的部分股东名册。截止7月10日，公司的股东人数为24490户。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100031353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0114","300049","BK0251","BK0096","BK0028","BK0113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652406102","title":"7月17日福瑞医科跌6.27%，平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652406102","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652406102?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:48","pubTimestamp":1784278120,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日福瑞医科跌6.27%，收盘报40.22元，换手率4.67%，成交量10.91万手，成交额4.51亿元。重仓福瑞医科的前十大公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共23家，其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300049","BK0146","BK0028","159760","BK0096","BK0114","BK0251","BK0113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651532094","title":"7月15日福瑞医科涨6.00%，平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651532094","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651532094?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:32","pubTimestamp":1784104375,"startTime":"0","endTime":"0","summary":"证券之星消息，7月15日福瑞医科涨6.00%，收盘报44.49元，换手率5.8%，成交量13.56万手，成交额5.95亿元。重仓福瑞医科的前十大公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共23家，其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0114","159760","BK0251","BK0028","300049","BK0113","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648169405","title":"7月1日福瑞医科涨12.91%，平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648169405","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648169405?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:50","pubTimestamp":1782895836,"startTime":"0","endTime":"0","summary":"证券之星消息，7月1日福瑞医科涨12.91%，收盘报43.9元，换手率5.9%，成交量13.77万手，成交额5.78亿元。重仓福瑞医科的前十大公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共23家，其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100031642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0028","BK0113","BK0096","159760","300049","BK0146","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646358660","title":"6月26日福瑞医科跌5.09%，平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646358660","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646358660?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:54","pubTimestamp":1782464098,"startTime":"0","endTime":"0","summary":"证券之星消息，6月26日福瑞医科跌5.09%创60日新低，收盘报37.14元，换手率3.31%，成交量7.74万手，成交额2.92亿元。重仓福瑞医科的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共23家，其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600030711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","300049","BK0113","BK0251","BK0146","BK0114","159760","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642407275","title":"6月11日福瑞医科涨6.03%，平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642407275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642407275?lang=zh_cn&edition=full","pubTime":"2026-06-11 16:32","pubTimestamp":1781166725,"startTime":"0","endTime":"0","summary":"证券之星消息，6月11日福瑞医科涨6.03%，收盘报42.75元，换手率4.95%，成交量11.57万手，成交额4.87亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共23家，其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A目前规模为17.03亿元，最新净值1.8551，较上一交易日上涨1.53%，近一年下跌28.13%。平安医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100025664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK0114","300049","BK0146","BK0113","BK0251","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640199134","title":"研报掘金丨华源证券：维持福瑞医科“买入”评级，海外装机与药企合作驱动增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2640199134","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640199134?lang=zh_cn&edition=full","pubTime":"2026-06-04 13:37","pubTimestamp":1780551422,"startTime":"0","endTime":"0","summary":"华源证券研报指出，福瑞医科业绩稳健增长，海外装机与药企合作驱动增长。依托互联网医院平台推进肝病全程管理，有效带动复方鳖甲软肝片销量稳步提升，为自有药品业务持续增长赋能。考虑到公司为肝病无创诊断龙头企业，受益于全球MASH赛道景气度持续提升、创新药研发持续突破以及下游药企协同推广，FibroScan海外终端需求有望持续释放，维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260604/32269808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["161027","300049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640473309","title":"股市必读：福瑞医科（300049）今年截至6月2日累计跌幅已超40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640473309","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640473309?lang=zh_cn&edition=full","pubTime":"2026-06-03 01:15","pubTimestamp":1780420512,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，福瑞医科报收于43.49元，下跌4.02%，换手率2.96%，成交量6.93万手，成交额3.04亿元。交易信息汇总股价提醒6月2日福瑞医科收盘报43.49元，跌4.02%，当日成交3.04亿元。该股已连续7日下跌，当年累计跌幅41.5%。前10个交易日主力资金累计净流出3.29亿元，股价累计下跌19.54%；融资余额累计减少2693.61万元，融券余量累计减少7.16万股。公司暂时不会考虑取消发行H股计划。截止5月29日，公司的股东人数为24510户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300001556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0114","300049","BK0251","BK0146","BK0028","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640991980","title":"福瑞医科：公司暂时不会考虑取消发行H股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2640991980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640991980?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:15","pubTimestamp":1780391724,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞医科(300049)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：事件迟迟没有进展消息，一拖再拖，公司有没有考虑终止H股发行以及子公司少数股权回购？福瑞医科回复：尊敬的投资者您好！公司暂时不会考虑取消发行H股计划。echosens二股东和相关受让方在积极谈判推进股权转让事宜，感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200032736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0028","BK0251","BK0114","BK0096","BK0146","300049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640916715","title":"福瑞医科：一季度业绩增速放缓原因","url":"https://stock-news.laohu8.com/highlight/detail?id=2640916715","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640916715?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:12","pubTimestamp":1780391544,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞医科(300049)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：去年三四季度看到公司营收利润有明显的增长，为何到了今年一季度增长速度明显降低？福瑞医科回复：尊敬的投资者您好！一季度业绩增速放缓原因：受中东局部地缘局势紧张、跨境区域物流周转不畅等外部因素影响，区域终端供货节奏短期承压，对应器械业务当期收入预计影响金额约160万欧元，随着当地物流链路、终端渠道秩序的恢复，相关区域后续经营将回归常态。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200032634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0251","BK0096","300049","BK0114","BK0028","BK0113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640167739","title":"福瑞医科：目前暂无明确递交及上市时间","url":"https://stock-news.laohu8.com/highlight/detail?id=2640167739","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640167739?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:12","pubTimestamp":1780391544,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞医科(300049)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：你好 请问港股上市筹划进行到哪一步了？为何半年过去了没有任何进展？考虑到香港ipo排队较长，是否考虑取消发行h股计划？福瑞医科回复：尊敬的投资者您好！目前暂无明确递交及上市时间，后续进展将依规及时公告。公司暂时不会考虑取消发行H股计划。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200032636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0146","BK0096","BK0114","BK0028","BK0251","300049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640916778","title":"福瑞医科：截止5月29日，公司的股东人数为24510户","url":"https://stock-news.laohu8.com/highlight/detail?id=2640916778","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640916778?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:12","pubTimestamp":1780391542,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞医科(300049)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：公司截止5月28日股东人数是多少福瑞医科回复：尊敬的投资人您好！根据相关规定，中国证券登记结算有限责任公司深圳分公司每月会向公司提供截至上月最后一个交易日、本月10日和本月20日（该日若为非交易日的，应为该日前一个交易日）的部分股东名册。截止5月29日，公司的股东人数为24510户。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200032631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300049","BK0146","BK0028","BK0096","BK0114","BK0251","BK0113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640167259","title":"福瑞医科：FDA已接受Echosens基于VCTE技术的LSM作为MASH临床试验替代终点的意向书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640167259","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640167259?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:12","pubTimestamp":1780391532,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞医科06月02日在投资者关系平台上答复投资者关心的问题。3福瑞医科回复：尊敬的投资人您好！公司持续保持和FDA 的沟通。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200032610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0251","300049","BK0028","BK0113","BK0146","BK0096"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786614358219,"stockEarnings":[{"period":"1week","weight":-0.0463},{"period":"1month","weight":0.0507},{"period":"3month","weight":-0.1987},{"period":"6month","weight":-0.3275},{"period":"1year","weight":-0.0923},{"period":"ytd","weight":-0.3656}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0332},{"period":"1year","weight":0.0766},{"period":"ytd","weight":-0.0056}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"内蒙古福瑞医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"24490人(较上一季度增加1.88%)","perCapita":"9538股","listingDate":"2010-01-20","address":"内蒙古自治区乌兰察布市集宁区解放路103号","registeredCapital":"26399万元","survey":"　　内蒙古福瑞医疗科技股份有限公司的主营业务是肝病领域的药品生产与销售、诊断设备研发与销售以及医疗服务相关业务。公司的主要产品是复方鳖甲软肝片。","listedPrice":28.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福瑞医科(300049)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福瑞医科(300049)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福瑞医科,300049,福瑞医科股票,福瑞医科股票老虎,福瑞医科股票老虎国际,福瑞医科行情,福瑞医科股票行情,福瑞医科股价,福瑞医科股市,福瑞医科股票价格,福瑞医科股票交易,福瑞医科股票购买,福瑞医科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福瑞医科(300049)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福瑞医科(300049)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}